Teva and Fosun Pharma Forge Alliance for Next-Gen Cancer Treatment Development Teva Pharmaceutical and Fosun Pharma have teamed up to expedite the development of TEV-56278, a novel anti-PD1-IL2 therapy aimed at improving cancer treatments.

Teva and Fosun Pharma Forge Alliance for Next-Gen Cancer Treatment Development #Israel #Tel_Aviv #Fosun_Pharma #Teva_Pharma #TEV-56278